Literature DB >> 34677082

Large-scale omics data reveal the cooperation of mutation-circRNA-miRNA-target gene network in liver cancer oncogenesis.

Jian Li1, Chun-Peng Yu1, Qun Li1, Shuai Chang1, Ling-Ling Xie1, Song Wang1.   

Abstract

Aims: Clarifying the initial trigger of the differentially expressed genes in cancers helps researchers understand the cellular system as a whole network. Materials & methods: We retrieve the transcriptome and translatome of tumor and normal tissues from ten liver cancer patients and define differentially expressed genes and tumor-specific mutations. We associate the oncogenesis with the mutations by target prediction and experimental verification.
Results: Upregulated genes have tumor-specific mutations in 3'UTRs that abolish the binding of miRNAs. For downregulated genes, their corresponding miRNAs are mutually targeted by two circRNAs, with mutations in base-pairing regions. Transfection experiments support the oncogenic role of these mutations. Conclusions: The tumor-specific mutations serve as the initial trigger of liver cancer. The mutation-circRNA-miRNA-target gene chain is completed.

Entities:  

Keywords:  circRNA; differentially expressed genes; liver cancer; miRNA; mutation

Mesh:

Substances:

Year:  2021        PMID: 34677082     DOI: 10.2217/fon-2021-0940

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  2 in total

1.  The Sponge Interaction Between Circular RNA and microRNA Serves as a Fast-Evolving Mechanism That Suppresses Non-small Cell Lung Cancer (NSCLC) in Humans.

Authors:  Liqun Wu; Meiling Cao; Xiaoxin Pu; Baoyi Liu; Jinxiang Wang
Journal:  J Mol Evol       Date:  2022-08-29       Impact factor: 3.973

2.  Hepatitis B virus (HBV) codon adapts well to the gene expression profile of liver cancer: an evolutionary explanation for HBV's oncogenic role.

Authors:  Chunpeng Yu; Jian Li; Qun Li; Shuai Chang; Yufeng Cao; Hui Jiang; Lingling Xie; Gang Fan; Song Wang
Journal:  J Microbiol       Date:  2022-10-17       Impact factor: 2.902

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.